The company partners with school districts to fill crucial gaps in preventative mental health resources, measurably improving student well-being and decreasing absenteeism
SACRAMENTO, Calif., Feb. 24, 2025 /PRNewswire/ — Sonar Mental Health (“Sonar”), an AI-powered mental health platform helping young people thrive, today announces $2.4M in pre-seed funding led by Nina Capital, with participation from GSR Ventures and J4 Ventures and support from the Stanford University Social Impact Founder Fellowship. Amid the worsening adolescent mental health crisis, Sonar will use this capital to accelerate its expansion across school districts nationwide, invest in R&D and app development, and continue building the most scalable, effective solution for preventative mental health support.
“Sonar isn’t merely a project or a job for me; I see it as my personal mission to prevent another family or friend from experiencing the tragedy of losing a loved one to mental illness,” said Drew Barvir, co-founder and CEO at Sonar. “Our team of experienced psychiatrists, counselors, researchers, and AI experts is unwavering in this shared passion for providing adolescents with the support they need to improve lifelong mental well-being while empowering under-resourced schools with proactive mental health solutions. This funding round allows us to continue making strides in supporting the next generation with the resources they need to become their healthiest, happiest, most engaged selves.”
The Mental Health Support System for Youth is Broken
The Sonar Way
Sonar’s preventative mental health support platform is designed to engage young people in a way that ensures they use it—and feel better because they did. The company’s AI-powered Wellbeing Companion, Sonny, engages with students directly through text messages when they need support. Through ongoing conversation, the on-demand companion learns and adapts to each student’s unique needs, offering tailored, judgment-free responses that make them feel seen and heard, whether they’re stressing about college applications, experiencing conflict with friends, or grieving a personal loss.
The platform sets students up for long-term success beyond the K-12 experience while providing school districts with a cost-effective, scalable solution to boost student engagement and academic performance while reducing chronic absenteeism.
Momentum & Adoption
“Nearly every school in the U.S. is under-resourced, with the mental health support system across school districts remaining completely disjointed,” said Marta-Gaia Zanchi, founder and Managing Partner at Nina Capital. “Sonar is bringing something entirely new to the market, supporting students all over the country with desperately needed mental health resources and creating learning environments where students flourish, actively participate, and lay the foundation for successful futures. We’re proud to be part of Sonar’s journey as the company creates a model for mental health support in schools that actually works.”
To learn more about Sonar Mental Health, visit https://www.sonarmentalhealth.com/
ABOUT SONAR MENTAL HEALTH
Sonar Mental Health (“Sonar”) is an AI-powered mental health platform helping young people thrive. In partnership with school districts across the nation, the company is addressing the adolescent mental health crisis to measurably improve student well-being and identify mental health challenges early. Sonar’s AI-powered Wellbeing Companion, Sonny, engages with students directly through text messages whenever they need support. The platform sets students up for long-term success while providing school districts with a cost-effective, scalable solution to boost student engagement and academic performance while reducing chronic absenteeism.
Learn more at https://www.sonarmentalhealth.com/.
MEDIA CONTACT:
Tess Pawlisch
608-333-9788
sonar@needlepr.com
SOURCE Sonar Mental Health
--Data presented at the American College of Cardiology Annual Scientific Session show that the reduction…
Discover the Oral Probiotic That’s Reshaping Dental Health—Backed by 75,000+ Users and Groundbreaking Science ProDentim…
Rybelsus® reduced major adverse cardiovascular events by 14% vs placebo in adults with type 2…
– Lorundrostat 50 mg dose achieved a 15.4 mmHg absolute reduction and 7.9 mmHg placebo-adjusted…
NeuroQuiet Reviews NeuroQuiet VANCOUVER, WA, March 29, 2025 (GLOBE NEWSWIRE) -- NeuroQuiet Reviews In a…
Ozempic® improved maximum walking distance by 13% vs placebo in adults with type 2 diabetes…